Clinical Research Directory
Browse clinical research sites, groups, and studies.
Clinical Trial on the Efficacy of Intralesional Triamcinolone Versus Candida Albicans Antigen in Treating Alopecia Areata
Sponsor: Universidad Autonoma de Nuevo Leon
Summary
The efficacy of two intralesional treatment modalities for alopecia areata will be determined. Thirty patients over the age of 6 with the diagnosis of alopecia areata on the scalp, with an extension of less than 50%, will be included. A comparison will be made between the effectiveness of intralesional Triamcinolone (standard first-line treatment) and intralesional Candida albicans antigen, with serial clinical and trichoscopic pictures at follow-up to evaluate the clinical response and associated adverse effects.
Key Details
Gender
All
Age Range
6 Years - Any
Study Type
INTERVENTIONAL
Enrollment
30
Start Date
2024-08-20
Completion Date
2025-12-31
Last Updated
2024-08-21
Healthy Volunteers
No
Conditions
Interventions
Candida Albicans Antigen Injection
subcutaneous administration of Candida albicans antigen
Locations (1)
Hospital Universitario "Dr. José Eleuterio González"
Monterrey, Nuevo León, Mexico